Press Releases :: ProMIS Neurosciences, Inc. (PMN)

Aug 15, 2022

ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results

Aug 2, 2022

ProMIS Neurosciences Presents at 2022 Alzheimer’s Association International Conference

Jul 27, 2022

ProMIS Neurosciences to Present at 2022 Alzheimer’s Association International Conference

Jul 8, 2022

ProMIS Neurosciences to Commence Trading on Nasdaq Under the Symbol “PMN”

Jun 27, 2022

PROMIS ANNOUNCES REVERSE SHARE SPLIT TO MEET NASDAQ LISTING CRITERIA

Jun 22, 2022

ProMIS Neurosciences Announces Debt Amendment and Conversion

Jun 22, 2022

ProMIS Neurosciences Announces Filing of Form 10 Registration Statement and Nasdaq Listing Application

Jun 22, 2022

ProMIS Neurosciences Announces Authorization of Series 1 Preferred Shares

May 17, 2022

ProMIS Neurosciences presents at the 2022 Neuro4D International Conference

May 13, 2022

ProMIS Neurosciences Announces First Quarter 2022 Results